share_log

Benchmark Reiterates Speculative Buy on Unicycive Therapeutics, Maintains $3 Price Target

Moomoo 24/7 ·  Apr 15 11:00

Benchmark analyst Bruce Jackson reiterates Unicycive Therapeutics (NASDAQ:UNCY) with a Speculative Buy and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment